Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
eNq1mN9v2jAQx9/5K6K8kxC6DjoFqo21G1KrMVq0aS+VSY5i5trp2ebH/vo5hG50ctTV4MfYzvfOvruPT07P1w8sWAJKKngvTKJWGADPRE75fS+c3F42u+F5v5EuyJLsLetErShph0HGiJS9sJyNpkC4jL5fX30E8z9g2G8EqZguIFPP1mlFWfSZyPk1Kco1QboUNA8eQM1F3gsLrbajQSoVGi/6K4E/ZUEySOPdyP7s4u7N/ngal2L/oaol4BXh91ZR4E6amUYErgZEwb3ATY2/J07aVI5BCo0ZjIiaj1AsaQ651cSMMAlORmar/AZwyUCVRqzi8SJ7kE7iZEHWY3gc2p1+b2YHaq2arWbS6bS73STpttpJ4mQK947KHgWziTi7Szrt9lnrJAYeM8KVlo6hGQlUhHkKCpWD53nlyQ7C44vBz6ksGNlEC1m4HhVBYqYBTfX720i5g1s0PGLmzP7R55qx+JVeT3a08ORxCaOB0FzVQONy7HoQA8EVrOsj6sY5td7lIgV5PNlfgtsZP9JTRjNXohnmaJBqMh7WA+2ILPhAJEzQHwy+UZ6LlTw+ZPaD6sn7YstJq2iBeXLXPuu+TU5PnWvoh8mgmvvlQqMoIDb4ofIQqgz5TBzKE5OUdqmnlDxWNm6bHJERBjVtTtORLCYNn7oyb4nur4iqCavop4tb1+z4qgE3N9tPqzTNe3/i6oZdHyw3uVjr+OszuypwLw2wRjs45koV8l0cr1araE5kU5pygWiGx+b63k3qr/v2cl1X7UvFRk+uT6tL73UBci20ly70Q5vU3f+7ZthqQ6GGA2JRMdkbOYcXx4fx3w7Vm9ujZ/DwZ2bbTRJFBffV5uipVfEw/Ju48ks0gPgym9Ga15DavEzj6iWm30jj8hWm3/gNFIfjMQ==
e2g25xXY9B46wEef
